BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36870200)

  • 1. Neutrophil extracellular traps as a unique target in the treatment of chemotherapy-induced peripheral neuropathy.
    Wang CY; Lin TT; Hu L; Xu CJ; Hu F; Wan L; Yang X; Wu XF; Zhang XT; Li Y; Yin HY; Jiang CY; Xin HL; Liu WT
    EBioMedicine; 2023 Apr; 90():104499. PubMed ID: 36870200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroendocrine Stress Axis-Dependence of Duloxetine Analgesia (Anti-Hyperalgesia) in Chemotherapy-Induced Peripheral Neuropathy.
    Staurengo-Ferrari L; Bonet IJM; Araldi D; Green PG; Levine JD
    J Neurosci; 2022 Jan; 42(3):405-415. PubMed ID: 34880120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of Chemotherapy-Induced Peripheral Neuropathy by Inhibiting C-X-C Motif Chemokine Receptor 2.
    Cho HS; Choi YI; Park SU; Han YS; Kwon J; Jung SJ
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rosmarinic Acid Mitigates Mitochondrial Dysfunction and Spinal Glial Activation in Oxaliplatin-induced Peripheral Neuropathy.
    Areti A; Komirishetty P; Kalvala AK; Nellaiappan K; Kumar A
    Mol Neurobiol; 2018 Sep; 55(9):7463-7475. PubMed ID: 29427084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton Pump Inhibitors Ameliorate Oxaliplatin-induced Peripheral Neuropathy: Retrospective Analysis of Two Real-world Clinical Databases.
    Kobayashi A; Ikemura K; Wakai E; Kondo M; Okuda M
    Anticancer Res; 2023 Dec; 43(12):5613-5620. PubMed ID: 38030205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High mobility group box-1-toll-like receptor 4-phosphatidylinositol 3-kinase/protein kinase B-mediated generation of matrix metalloproteinase-9 in the dorsal root ganglion promotes chemotherapy-induced peripheral neuropathy.
    Gu H; Wang C; Li J; Yang Y; Sun W; Jiang C; Li Y; Ni M; Liu WT; Cheng Z; Hu L
    Int J Cancer; 2020 May; 146(10):2810-2821. PubMed ID: 31465111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage Toll-like Receptor 9 Contributes to Chemotherapy-Induced Neuropathic Pain in Male Mice.
    Luo X; Huh Y; Bang S; He Q; Zhang L; Matsuda M; Ji RR
    J Neurosci; 2019 Aug; 39(35):6848-6864. PubMed ID: 31270160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Targeting of Neutrophil Extracellular Traps Improves Primary and Secondary Intention Wound Healing in Mice.
    Heuer A; Stiel C; Elrod J; Königs I; Vincent D; Schlegel P; Trochimiuk M; Appl B; Reinshagen K; Raluy LP; Boettcher M
    Front Immunol; 2021; 12():614347. PubMed ID: 33717100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ergothioneine ameliorates oxaliplatin-induced peripheral neuropathy in rats.
    Nishida K; Takeuchi K; Hosoda A; Sugano S; Morisaki E; Ohishi A; Nagasawa K
    Life Sci; 2018 Aug; 207():516-524. PubMed ID: 29981320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NET-Triggered NLRP3 Activation and IL18 Release Drive Oxaliplatin-Induced Peripheral Neuropathy.
    Lin T; Hu L; Hu F; Li K; Wang CY; Zong LJ; Zhao YQ; Zhang X; Li Y; Yang Y; Wang Y; Jiang CY; Wu X; Liu WT
    Cancer Immunol Res; 2022 Dec; 10(12):1542-1558. PubMed ID: 36255412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombomodulin alfa prevents oxaliplatin-induced neuropathic symptoms through activation of thrombin-activatable fibrinolysis inhibitor and protein C without affecting anti-tumor activity.
    Minami T; Takeda M; Sata M; Kato H; Yano K; Sakai T; Tsujita R; Kawasaki K; Ito A
    Eur J Pharmacol; 2020 Aug; 880():173196. PubMed ID: 32416186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoting AMPK/SR-A1-mediated clearance of HMGB1 attenuates chemotherapy-induced peripheral neuropathy.
    Yang X; Jia R; Hu F; Fan W; Lin T; Zhang X; Xu C; Ruan S; Jiang C; Li Y; Pan C; Yang Y; Hu L; Chen Q; Liu WT
    Cell Commun Signal; 2023 May; 21(1):99. PubMed ID: 37143083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidants Improve Oxaliplatin-Induced Peripheral Neuropathy in Tumor-Bearing Mice Model: Role of Spinal Cord Oxidative Stress and Inflammation.
    Agnes JP; Santos VWD; das Neves RN; Gonçalves RM; Delgobo M; Girardi CS; Lückemeyer DD; Ferreira MA; Macedo-Júnior SJ; Lopes SC; Spiller F; Gelain DP; Moreira JCF; Prediger RD; Ferreira J; Zanotto-Filho A
    J Pain; 2021 Aug; 22(8):996-1013. PubMed ID: 33774154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Dual Role of Neutrophil Extracellular Traps (NETs) in Sepsis and Ischemia-Reperfusion Injury: Comparative Analysis across Murine Models.
    Kiwit A; Lu Y; Lenz M; Knopf J; Mohr C; Ledermann Y; Klinke-Petrowsky M; Pagerols Raluy L; Reinshagen K; Herrmann M; Boettcher M; Elrod J
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p38/TF/HIF-
    Yang Y; Hu L; Wang C; Yang X; Song L; Jiang C; Li Y; Li T; Liu WT; Feng J
    Biomed Res Int; 2019; 2019():5347804. PubMed ID: 31380428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin-associated neuropathy characteristics compared with those associated with other neurotoxic chemotherapy agents (Alliance A151724).
    Albany C; Dockter T; Wolfe E; Le-Rademacher J; Wagner-Johnston N; Einhorn L; Lafky JM; Smith E; Pachman D; Staff N; Ma C; Loprinzi CL; Costello BA
    Support Care Cancer; 2021 Feb; 29(2):833-840. PubMed ID: 32500206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal Antibody Targeting the Matrix Metalloproteinase 9 Prevents and Reverses Paclitaxel-Induced Peripheral Neuropathy in Mice.
    Tonello R; Lee SH; Berta T
    J Pain; 2019 May; 20(5):515-527. PubMed ID: 30471427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orally active Epac inhibitor reverses mechanical allodynia and loss of intraepidermal nerve fibers in a mouse model of chemotherapy-induced peripheral neuropathy.
    Singhmar P; Huo X; Li Y; Dougherty PM; Mei F; Cheng X; Heijnen CJ; Kavelaars A
    Pain; 2018 May; 159(5):884-893. PubMed ID: 29369966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective HCN1 block as a strategy to control oxaliplatin-induced neuropathy.
    Resta F; Micheli L; Laurino A; Spinelli V; Mello T; Sartiani L; Di Cesare Mannelli L; Cerbai E; Ghelardini C; Romanelli MN; Mannaioni G; Masi A
    Neuropharmacology; 2018 Mar; 131():403-413. PubMed ID: 29339292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil extracellular traps as a unique target in the treatment of inflammatory pain.
    Qin W; Li Y; Cui J; Yu B; Yu L; Yang C
    Biochem Biophys Res Commun; 2024 May; 710():149896. PubMed ID: 38604072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.